Rhythm Pharmaceuticals Lands $40,000,000 Series A Funding

  • Feed Type
  • Date
    12/11/2015
  • Company Name
    Rhythm Pharmaceuticals
  • Mailing Address
    855 Boylston Street 11th Floor Boston, MA 02116 USA
  • Company Description
    Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases.
  • Website
    http://www.rhythmtx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed